Survival analysis of PAH patients based on a multidimensional risk approach at baseline in Uruguay: 10 years of experience of a PH referral centre.
J. Grignola (Montevideo, Uruguay), A. Gruss (Montevideo, Uruguay), G. Pascal (Montevideo, Uruguay), C. Chao (Montevideo, Uruguay), J. Salisbury (Montevideo, Uruguay), C. Bedo (Montevideo, Uruguay), A. Coppola (Montevideo, Uruguay), B. Janssen (Montevideo, Uruguay), P. Trujillo (Montevideo, Uruguay), P. Curbelo (Montevideo, Uruguay)
Source: International Congress 2019 – Pulmonary hypertension: clinical
Session: Pulmonary hypertension: clinical
Session type: Thematic Poster
Number: 4763
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Grignola (Montevideo, Uruguay), A. Gruss (Montevideo, Uruguay), G. Pascal (Montevideo, Uruguay), C. Chao (Montevideo, Uruguay), J. Salisbury (Montevideo, Uruguay), C. Bedo (Montevideo, Uruguay), A. Coppola (Montevideo, Uruguay), B. Janssen (Montevideo, Uruguay), P. Trujillo (Montevideo, Uruguay), P. Curbelo (Montevideo, Uruguay). Survival analysis of PAH patients based on a multidimensional risk approach at baseline in Uruguay: 10 years of experience of a PH referral centre.. 4763
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Cluster analysis identifying patients with COPD at high-risk of 2-year mortality: preliminary results. Source: International Congress 2017 – Assessing the functional status of patients with COPD Year: 2017
Trends of asthma in Mexico. A 10 years analysis in a nationwide health institution Source: Eur Respir J 2002; 20: Suppl. 38, 317s Year: 2002
Real time qualitative primary-care based study related to the validity of the diagnosis and management of patients held on COPD registers in primary care Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019
Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data. Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021
Prediction of one or two years’ exacerbation free time in primary care COPD patients, a validated prediction nomogram Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017
Long-term (4 years) experience of Nintedanib in IPF patients in Crete: A real life data study Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018
Direct cost analysis of COPD patients: A 1 year follow-up study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016
Identifying predictors of healthcare utilization and costs in COPD patients over 18 months: first longitudinal results of the COSYCONET cohort Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018
COPD patients´ perspectives at the time of diagnosis: a qualitative study Source: Eur Respir J 2006; 28: Suppl. 50, 740s Year: 2006
Association between chronic comorbidity and exacerbation rate in primary care COPD patients. Preliminary analysis of real-life general practice data (PROSPECT1) Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016
Using a Bayesian approach and external validation to predict persistent asthma at the age of 10 and 20 years in general and high-risk populations Source: International Congress 2018 – Recent insights in childhood asthma and wheezing Year: 2018
Intensive care results and costs of advanced age patients with respiratory failure: 3 years cohort study Source: Annual Congress 2011 - Intensive care outcome Year: 2011
Using the ADO score in primary care to target pulmonary rehabilitation to patients at high risk of hospital admission Source: International Congress 2016 – Management of asthma and COPD in primary care Year: 2016
Use of prognostic indicators to identify patients with end stage COPD: A survey of South-West (SW) England clinicians Source: Annual Congress 2013 –The best posters in chronic care Year: 2013
An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
E-Health services for home monitoring and rehabilitation in COPD patients (preliminary report with 6 months follow up) Source: Eur Respir J 2004; 24: Suppl. 48, 245s Year: 2004
How to protect children from the risk of tuberculosis disease? The contact study. Management suggestions based on a 11 year experience Source: Eur Respir J 2002; 20: Suppl. 38, 549s Year: 2002
A multidisciplinary approach in the global treatment of severe COPD reduces hospitalisation during 3 years in a rural part of the province of Quebec, Canada Source: Eur Respir J 2004; 24: Suppl. 48, 90s Year: 2004
Incidence and burden of major comorbidities among individuals with COPD: a comprehensive analysis using data from primary care Source: Annual Congress 2009 - Risk factors for COPD Year: 2009
Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study Source: Eur Respir J, 56 (2) 2001104; 10.1183/13993003.01104-2020 Year: 2020